Hostname: page-component-7b7567c8c-tnzcf Total loading time: 0 Render date: 2026-11-14T08:26:28.157Z Has data issue: false hasContentIssue false

Rhodococcus

Published online by Cambridge University Press:  21 June 2016

Robert D. Walsh
Affiliation:
Infectious Disease Division and the Department of Pathology, Winthrop-University Hospital, Mineola, New York, and the University of New York School of Medicine, Stony Brook, New York
Paul E. Schochd
Affiliation:
Infectious Disease Division and the Department of Pathology, Winthrop-University Hospital, Mineola, New York, and the University of New York School of Medicine, Stony Brook, New York
Burke A. Cunha*
Affiliation:
Infectious Disease Division and the Department of Pathology, Winthrop-University Hospital, Mineola, New York, and the University of New York School of Medicine, Stony Brook, New York
*
Winthrop-University Hospital, Mineola, NY 11501

Extract

Infections due to Rhodococcus species are being reported with increasing frequency, especially among immunocompromised and HIV patients. R equi is the most commonly isolated species, usually from HIV patients with chronic cavitary pneumonia. Other species of Rhodococcus involved in human infections include R bronchialis, R terrae, R rhodochrous, and R aurantiacus.

Organisms belonging to the genus Rhodococcus are widely distributed in nature, but are particularly abundant in soil. Trauma, steroids, immunosuppressive therapy, surgical procedures, HIV and immune-compromised status predispose patients to infection with Rhodococcus.

Information

Type
Topics in Clinical Microbiology
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1993 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable